AI assistant
Sending…
Monogram Technologies Inc. — Director's Dealing 2024
Apr 26, 2024
33540_dirs_2024-04-26_2ee1707e-c12c-48ed-94ba-32729939175e.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: MONOGRAM ORTHOPAEDICS INC (MGRM)
CIK: 0001769759
Period of Report: 2024-04-24
Reporting Person: Knape Noel (Chief Financial Officer)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2024-04-24 | Stock Option | $2.33 | A | 25000 | Acquired | 2024-04-24 | Common Stock (25000) | Direct |
Footnotes
F1: The options were issued under the Company's 2019 Stock Option and Grant Plan.
F2: 25% of the shares of Common Stock underlying the options will vest on the 1-year anniversary of the date of grant, and the remaining 75% of such shares shall vest in 12 equal 6-month installments over the next six years, becoming fully vested on April 24, 2030 (provided that Mr. Knape continues to have a service relationship with the Company as of the date of each vesting described herein).
More from Monogram Technologies Inc.
Regulatory Filings
2025
Nov 20
Regulatory Filings
2025
Nov 20
Regulatory Filings
2025
Oct 21
Director's Dealing
2025
Oct 15
Director's Dealing
2025
Oct 15
Director's Dealing
2025
Oct 15
Regulatory Filings
2025
Oct 7
Capital/Financing Update
2025
Oct 7
Regulatory Filings
2025
Oct 7
Director's Dealing
2025
Oct 7